← FDA Drug Approvals (Drugs@FDA)
APOKYN
NDA · New Drug Application · Sponsor: MDD US · Approved 2004-04-20
Drug application
- FDA Application #
NDA021264- Application type
- New Drug Application
- Brand name
- APOKYN
- Generic name
- Apomorphine Hydrochloride
- Active ingredients
- APOMORPHINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- MDD US
- First approval
- 2004-04-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown